Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Hovnanian Enterprises
HOV
$726M
| $1.69M | ﹤0.01% |
13,281
+812
| +7% | +$80.1K |
|
|
CMBM
2752
DELISTED
Cambium Networks
CMBM
| $1.69M | ﹤0.01% |
65,856
+1,330
| +2% | +$38.5K |
|
2753
Regis Corp
RGS
$68.4M
| $1.68M | ﹤0.01% |
48,290
+19,062
| +65% | +$1.04M |
|
|
IGMS
2754
DELISTED
IGM Biosciences
IGMS
| $1.68M | ﹤0.01% |
57,121
+1,254
| +2% | +$62.3K |
|
|
TUYA
2755
Tuya Inc
TUYA
$1.03B
| $1.68M | ﹤0.01% |
268,004
+201,461
| +303% | +$1.37M |
|
|
ACRE
2756
Ares Commercial Real Estate
ACRE
$236M
| $1.67M | ﹤0.01% |
114,943
+2,072
| +2% | +$31.6K |
|
2757
Shattuck Labs
STTK
$675M
| $1.67M | ﹤0.01% |
196,376
+2,559
| +1% | +$35.3K |
|
|
KDNY
2758
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.67M | ﹤0.01% |
102,101
+17,501
| +21% | +$249K |
|
2759
RCI Hospitality Holdings
RICK
$192M
| $1.66M | ﹤0.01% |
21,334
+454
| +2% | +$31.6K |
|
2760
BARK
BARK
$81.8M
| $1.66M | ﹤0.01% |
19,643
+379
| +2% | +$43.4K |
|
2761
Aligos Therapeutics
ALGS
$26.2M
| $1.65M | ﹤0.01% |
5,563
+150
| +3% | +$54.7K |
|
|
CATC
2762
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.65M | ﹤0.01% |
17,586
+360
| +2% | +$32.9K |
|
|
ORC
2763
Orchid Island Capital
ORC
$1.3B
| $1.64M | ﹤0.01% |
72,955
+9,093
| +14% | +$218K |
|
2764
Veritone
VERI
$101M
| $1.64M | ﹤0.01% |
72,994
+1,368
| +2% | +$35.1K |
|
2765
Passage Bio
PASG
$14.4M
| $1.63M | ﹤0.01% |
12,856
+320
| +3% | +$52.3K |
|
2766
Sutro Biopharma
STRO
$401M
| $1.63M | ﹤0.01% |
10,955
+168
| +2% | +$30.1K |
|
|
SFT
2767
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $1.63M | ﹤0.01% |
47,628
+1,227
| +3% | +$67.2K |
|
|
NOTV
2768
DELISTED
Inotiv
NOTV
| $1.62M | ﹤0.01% |
38,501
-22,769
| -37% | -$1.02M |
|
2769
Hingham Institution for Saving
HIFS
$627M
| $1.62M | ﹤0.01% |
3,851
+89
| +2% | +$33.6K |
|
|
BASE
2770
DELISTED
Couchbase
BASE
| $1.6M | ﹤0.01% |
63,972
+3,913
| +7% | +$129K |
|
2771
Byrna Technologies
BYRN
$103M
| $1.59M | ﹤0.01% |
119,336
+1,534
| +1% | +$25K |
|
|
FXLV
2772
DELISTED
F45 Training Holdings Inc.
FXLV
| $1.59M | ﹤0.01% |
146,328
+1,954
| +1% | +$24.4K |
|
|
EPZM
2773
DELISTED
Epizyme, Inc
EPZM
| $1.59M | ﹤0.01% |
637,481
+8,403
| +1% | +$33K |
|
2774
Quince Therapeutics
QNCX
$22.9M
| $1.59M | ﹤0.01% |
630
+9
| +1% | +$54.9K |
|
2775
Roblox
RBLX
$25.4B
| $1.58M | ﹤0.01% |
15,304
+164
| +1% | +$15.9K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.